Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168425 · ClinicalTrials.gov registry record · NA
Opioid Prescribing After Cesarean Delivery
A NA study of Surgery and Opioid Use, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT03168425: Completed NA study of Surgery and Opioid Use, sponsored by Vanderbilt University Medical Center.
NCT03168425 is a NA study of Surgery and Opioid Use that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 190 participants, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168425, a NA study of Surgery and Opioid Use, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion. Adjusting post- cesarean delivery opioid prescribing practices to better match actual patient need has the potential to reduce unused opioids available for diversion, nonmedical use, and development of chronic dependence, as well as reduce wasted resources.
Primary Outcome
oxycodone 5mg tablet leftover from prescription at discharge
Conditions Studied
Interventions
- OTHER Control
- OTHER Tailored prescription
Study Locations (1)
Tennessee
- Sarah Osmundson - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2017-09-21 |
| Phase | NA |
What the finished NCT03168425 record still lists
NCT03168425 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 52,850-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT03168425 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03168425 about?
NCT03168425 is a clinical study titled "Opioid Prescribing After Cesarean Delivery". The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primar...
What is the current status of trial NCT03168425?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2017-06-14. Estimated completion is 2017-09-21.
What conditions does trial NCT03168425 study?
This clinical trial studies the following conditions: Surgery, Opioid Use.
What interventions are being tested in trial NCT03168425?
The interventions under investigation include: Control (OTHER), Tailored prescription (OTHER).
Who is sponsoring clinical trial NCT03168425?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168425 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03168425's enrollment target sits among peer trials
190 42nd of 120 higher than 79 of 120 other Surgery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of the Use of 3D Technology to Guide Head and Neck Surgery
RECRUITING · NA
-
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
RECRUITING · NA
-
Ultrasound Evaluation for Improving Patient Selection in vNOTES
RECRUITING · NA
-
Gastric US in ICU Patient
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Physical Therapy After Endometriosis Excision
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI